X-48479062-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000348411.3(FTSJ1):āc.307C>Gā(p.Gln103Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,205,974 control chromosomes in the GnomAD database, including 12 homozygotes. There are 381 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000348411.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTSJ1 | NM_012280.4 | c.307C>G | p.Gln103Glu | missense_variant | 5/13 | ENST00000348411.3 | NP_036412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTSJ1 | ENST00000348411.3 | c.307C>G | p.Gln103Glu | missense_variant | 5/13 | 1 | NM_012280.4 | ENSP00000326948 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00579 AC: 652AN: 112557Hom.: 6 Cov.: 24 AF XY: 0.00481 AC XY: 167AN XY: 34719
GnomAD3 exomes AF: 0.00166 AC: 304AN: 183269Hom.: 2 AF XY: 0.000945 AC XY: 64AN XY: 67721
GnomAD4 exome AF: 0.000686 AC: 750AN: 1093363Hom.: 6 Cov.: 29 AF XY: 0.000596 AC XY: 214AN XY: 359023
GnomAD4 genome AF: 0.00581 AC: 654AN: 112611Hom.: 6 Cov.: 24 AF XY: 0.00480 AC XY: 167AN XY: 34783
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 31, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at